UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.     )

 

 

☒    Filed by the Registrant                             ☐    Filed by a Party other than the Registrant

Check the appropriate box:

 

  Preliminary Proxy Statement
  CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material Pursuant to §240.14a-12

MEDTRONIC PLC

LOGO

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

  No fee required.
  Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

  Fee paid previously with preliminary materials.
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

2020 Annual General Meeting to Be Held Virtually on December 11, 2020.

 

   MEDTRONIC PLC  

 

Meeting Information

 

Meeting Type:            Annual General Meeting

For holders as of:      October 15, 2020

     Date:    December 11, 2020      Time:  9:00 AM U.S. Central  Time
                                                                    (3:00 PM Irish Time)
 
     Location:  Meeting live via the Internet-please visit
    

  www.virtualshareholdermeeting.com/MDT2020.

 

  

 

 

MEDTRONIC PLC

ATTN: MARCY CAMAROTTO

710 MEDTRONIC PARKWAY

MS LC300

MINNEAPOLIS, MN 55432-5604

 

 

You are receiving this communication because you hold shares in the company named above.

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com, or scan the QR Barcode on the reverse side, or easily request a paper copy (see reverse side).

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

LOGO          

 

See the reverse side of this notice to obtain

proxy materials and voting instructions.

 

    
    
    
    
    


  Before You Vote
      

    How to Access the Proxy Materials

 

      

 

Proxy Materials Available to VIEW or RECEIVE:

 

 

PROXY STATEMENT                        ANNUAL REPORT

 

 

How to View Online:

 

 

Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com, or scan the QR Barcode below.

 

 

How to Request and Receive a PAPER or E-MAIL Copy:

 

  If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
   
 

1) BY INTERNET:

   www.proxyvote.com
 

2) BY TELEPHONE:

   1-800-579-1639
 

3) BY E-MAIL*:

 

  

sendmaterial@proxyvote.com

 

 

*  If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

 

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor.

Please make the request as instructed above on or before November 29, 2020 to facilitate timely delivery.

 

 

 

How To Vote

    Please Choose One of the Following Voting Methods

 

  

LOGO

 

LOGO

    

    

    

 

 

Vote By Internet:

 

Before The Meeting:

 

Go to www.proxyvote.com or from a smartphone, scan the QR Barcode above. Have the information that is printed in the box marked by the arrow LOGO (located on the following page) available and follow the instructions.

 

During The Meeting:

 

Go to www.virtualshareholdermeeting.com/MDT2020. Have the information that is printed in the box marked by the arrow LOGO (located on the following page) available and follow the instructions.

 

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

 

Vote By Phone: To vote by telephone, go to www.proxyvote.com to view the proxy materials and obtain the toll free number to call. Have the information that is printed in the box marked by the arrow LOGO (located on the following page) available and follow the instructions.

 

 


      

 

Voting Items

 

 

 

 

The Board of Directors recommends you vote FOR the following proposals:

 

LOGO

 

  1.  

To elect, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2021 Annual General Meeting of the Company.

 

   

Nominees:

 

   

1a.

 

  Richard H. Anderson
   

1b.

 

  Craig Arnold
   

1c.

 

  Scott C. Donnelly
   

1d.

 

  Andrea J. Goldsmith, Ph.D.
   

1e.

 

  Randall J. Hogan, III
   

1f.

 

  Michael O. Leavitt
   

1g.

 

  James T. Lenehan
   

1h.

 

  Kevin E. Lofton
   

1i.

 

  Geoffrey S. Martha
   

1j.

 

  Elizabeth G. Nabel, M.D.
   

1k.

 

  Denise M. O’Leary
   

1l.

 

  Kendall J. Powell
     
     
     
     

 

 

2.    

To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal year 2021 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor’s remuneration.

3.  

To approve, in a non-binding advisory vote, named executive officer compensation (a “Say-on-Pay” vote).

4.  

To renew the Board’s authority to issue shares.

5.  

To renew the Board’s authority to opt out of pre-emption rights.

6.  

Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.

7.  

Transacting any other business that may properly come before the meeting.

 

 


 

 

 

 

 

LOGO